HK1083601A1 - Use of alpha-1 antitrypsin for the preparation of medicaments for the treatment of fibromyalgia - Google Patents

Use of alpha-1 antitrypsin for the preparation of medicaments for the treatment of fibromyalgia

Info

Publication number
HK1083601A1
HK1083601A1 HK06105870A HK06105870A HK1083601A1 HK 1083601 A1 HK1083601 A1 HK 1083601A1 HK 06105870 A HK06105870 A HK 06105870A HK 06105870 A HK06105870 A HK 06105870A HK 1083601 A1 HK1083601 A1 HK 1083601A1
Authority
HK
Hong Kong
Prior art keywords
fibromyalgia
antitrypsin
medicaments
alpha
preparation
Prior art date
Application number
HK06105870A
Other languages
English (en)
Inventor
Ignacio Blanco Blanco
Original Assignee
Grifols Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grifols Sa filed Critical Grifols Sa
Publication of HK1083601A1 publication Critical patent/HK1083601A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK06105870A 2004-09-24 2006-05-22 Use of alpha-1 antitrypsin for the preparation of medicaments for the treatment of fibromyalgia HK1083601A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200402282A ES2281222B1 (es) 2004-09-24 2004-09-24 Utilizacion de alfa-1 antitripsina para la preparacion de medicamentos para el tratamiento de la fibromialgia.

Publications (1)

Publication Number Publication Date
HK1083601A1 true HK1083601A1 (en) 2006-07-07

Family

ID=35875051

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06105870A HK1083601A1 (en) 2004-09-24 2006-05-22 Use of alpha-1 antitrypsin for the preparation of medicaments for the treatment of fibromyalgia

Country Status (16)

Country Link
US (1) US7291595B2 (xx)
EP (1) EP1656949B1 (xx)
JP (1) JP4351663B2 (xx)
CN (1) CN100354000C (xx)
AR (1) AR054210A1 (xx)
AU (1) AU2005203400B2 (xx)
BR (1) BRPI0503821B8 (xx)
CA (1) CA2514816C (xx)
DE (1) DE602005000442T2 (xx)
ES (2) ES2281222B1 (xx)
HK (1) HK1083601A1 (xx)
MX (1) MXPA05008543A (xx)
NZ (1) NZ541743A (xx)
PL (1) PL1656949T3 (xx)
PT (1) PT1656949E (xx)
UY (1) UY29056A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8623830B2 (en) * 2006-09-12 2014-01-07 Beth Israel Deaconess Medical Center, Inc. Compositions containing α-1-antitrypsin and methods for use
US20110237496A1 (en) * 2008-09-10 2011-09-29 Ilana Nathan Antinecrotic activity of alpha 1-antitrypsin
ES2332645B1 (es) * 2009-06-30 2010-10-18 Grifols, S.A. Utilizacion de alfa-1-antitripsina para la preparacion de medicamentos para el tratamiento del sindrome de fatiga cronica.
BR112015019348A2 (pt) 2013-02-13 2017-08-22 Lab Francais Du Fractionnement Métodos para produção de proteína com glicosilação modificada e com sialilação aumentada, para aumentar a atividade de sialil transferase na glândula mamária e para produzir sialil transferase, proteína com glicosilação modificada ou proteína com sialilação aumentada, composição, sialil transferase, mamífero transgênico, e, célula epitelial mamária

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440679A (en) 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
US5612051A (en) * 1995-11-17 1997-03-18 Yue; Samuel K. Method of treating involuntary muscle dysfunction with relaxin hormone
US6610324B2 (en) * 1999-04-07 2003-08-26 The Mclean Hospital Corporation Flupirtine in the treatment of fibromyalgia and related conditions
MXPA02007187A (es) * 2000-01-25 2002-12-09 Aeropharm Technology Inc Fromulacion medicinal en aerosol.
DE10022092A1 (de) 2000-05-08 2001-11-15 Aventis Behring Gmbh Stabilisiertes Protein-Präparat und Verfahren zu seiner Herstellung
CA2312109A1 (en) * 2000-06-23 2001-12-23 Universite De Sherbrooke Use of furin and furin-like protease inhibitors in the treatment of inflammatory or matrix remodelling diseases

Also Published As

Publication number Publication date
BRPI0503821A (pt) 2006-05-09
BRPI0503821B8 (pt) 2021-05-25
CA2514816C (en) 2010-12-07
BRPI0503821B1 (pt) 2018-02-06
US7291595B2 (en) 2007-11-06
ES2279498T3 (es) 2007-08-16
ES2281222B1 (es) 2008-06-01
CN1751739A (zh) 2006-03-29
PT1656949E (pt) 2007-04-30
CN100354000C (zh) 2007-12-12
MXPA05008543A (es) 2006-03-28
AU2005203400B2 (en) 2007-01-18
DE602005000442T2 (de) 2007-11-15
DE602005000442D1 (de) 2007-02-22
UY29056A1 (es) 2006-02-24
CA2514816A1 (en) 2006-03-24
AR054210A1 (es) 2007-06-13
PL1656949T3 (pl) 2007-06-29
EP1656949B1 (en) 2007-01-10
JP4351663B2 (ja) 2009-10-28
NZ541743A (en) 2005-12-23
US20060084598A1 (en) 2006-04-20
AU2005203400A1 (en) 2006-04-13
EP1656949A1 (en) 2006-05-17
JP2006089478A (ja) 2006-04-06
ES2281222A1 (es) 2007-09-16

Similar Documents

Publication Publication Date Title
ZA200703601B (en) Medicaments for the treatment or prevention of fibriotic diseases
IL183101A (en) Use of tetrahydrocannabivarin in drug production
HUS1500058I1 (hu) Benzoxazint tartalmazó gyógyszer-kombináció légúti betegségek kezelésére
IL177490A0 (en) Methods for the treatment of tinnitus induced by cochlear excitotoxicity
IL178816A0 (en) The treatment of childhood asthma
IL184124A0 (en) Medicaments for the treatment or prevention of fibrotic diseases
IL179337A0 (en) Pharmaceutical compositions for the treatment of pruritus
PT1670482E (pt) Utilização de ciclesonida para o tratamento de doenças respiratórias
EP1952811A4 (en) USE OF ERIOCALYXIN B FOR THE MANUFACTURE OF MEDICAMENTS FOR THE TREATMENT OF LEUKEMIA
HK1083601A1 (en) Use of alpha-1 antitrypsin for the preparation of medicaments for the treatment of fibromyalgia
HU0500145D0 (en) Composition for the treatment of oral diseases
EP1757282A4 (en) USE OF KAURANE COMPOUNDS IN THE MANUFACTURE OF MEDICAMENTS
EP1737475A4 (en) VEGETABLE THERAPY FOR THE TREATMENT OF ASTHMA
GB0415181D0 (en) Compounds for use in the treatment of infection
ZA200606780B (en) Compounds for the treatment of diseases
GB0425073D0 (en) Compounds for the treatment of diseases
IL177531A0 (en) Compounds for the treatment of diseases
GB0420867D0 (en) Compounds for the treatment of diseases
SI1670482T1 (sl) Uporaba ciklezonida za zdravljenje respiratornih bolezni
AU2004903986A0 (en) Compounds for the Treatment of Vascular Diseases
GB0425064D0 (en) Compounds useful for the treatment of diseases
AP2006003743A0 (en) Compounds useful for the treatment of diseases
GB0410231D0 (en) Dental treatment strips
GB0420655D0 (en) Dental treatment strips
AP2007003952A0 (en) Use of an anti-atherothrombotic compound inobtaining medicaments intended for the treatment of vascular disorders

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220827